Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients

In the era of immunotherapies there is an urgent need to implement the use of circulating biomarkers in clinical practice to facilitate personalized therapy and to predict treatment response. We conducted a prospective study to evaluate the usefulness of circulating exosomal-PD-L1 in melanoma patien...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Marine Cordonnier, Charlée Nardin, Gaëtan Chanteloup, Valentin Derangere, Marie-Paule Algros, Laurent Arnould, Carmen Garrido, François Aubin, Jessica Gobbo
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2020-01-01
Serie:	Journal of Extracellular Vesicles
Soggetti:	melanoma exosome pd-l1/pd-1 immune checkpoint follow-up
Accesso online:	http://dx.doi.org/10.1080/20013078.2019.1710899
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!